Melatonin for Sleep: Benefits, Timing, and Safety

Melatonin may help when a sleep problem is mainly about timing, such as some circadian-rhythm disorders or jet lag. It is not a universal treatment for difficulty sleeping, and it should not be treated as a harmless sedative simply because the body also makes melatonin.

The most useful first question is not “What dose should I take?” It is “What problem am I trying to treat?” Persistent insomnia, a delayed body clock, travel across time zones, and sleep after a night shift are different problems. Evidence for one cannot be transferred to another.

The hormone your body makes is not the same as a supplement plan

Endogenous melatonin is the hormone produced by the body. The brain releases it in response to darkness as part of the system that coordinates circadian rhythms, the roughly 24-hour patterns that help organize sleep and wakefulness. Light at night can suppress this production ¹.

Exogenous melatonin is melatonin taken as a product. It enters the body at the clock time chosen by the user, which may or may not match the person's internal biological time. Depending on when it is taken, melatonin can shift the circadian clock as well as increase sleepiness.

The American Academy of Sleep Medicine describes a phase-response pattern: melatonin taken in the afternoon or evening tends to shift circadian timing earlier, while morning use tends to shift it later. The guideline also says that optimal dosing for circadian effects remains unclear and that timing may matter more than dose ². This is why a generic instruction such as “take it at bedtime” is not a treatment plan for a circadian disorder.

Melatonin can have a direct sleepiness-producing effect, but it does not work like every prescription or over-the-counter sedative. A person may feel drowsy without correcting the timing problem, or may shift the clock in an unhelpful direction if the timing is wrong.

When melatonin may help

Sleep problem	What the evidence says	What that means in practice
Chronic insomnia	The AASM suggests that clinicians not use melatonin for sleep-onset or sleep-maintenance insomnia in adults. The recommendation is weak because the evidence base was very limited, not because every study proved no effect 3.	Persistent insomnia needs evaluation of causes and maintaining factors. CBT-I is the first-line treatment for most adults 4.
Delayed sleep-wake phase disorder	AASM guidance conditionally supports strategically timed melatonin for adults with this diagnosed circadian disorder. Timing is part of the treatment, not an accessory detail 2.	Confirm that sleep is delayed rather than generally poor. A sleep diary and clinician-led timing plan are more useful than a standard bedtime dose.
Other circadian-rhythm disorders	Evidence differs by diagnosis and population. The same guideline found no evidence to support melatonin for advanced sleep-wake phase disorder and conditionally supported it for some blind adults with non-24-hour sleep-wake rhythm disorder 2.	Do not self-diagnose from bedtime alone. Advanced, delayed, irregular, and non-24-hour patterns require different approaches.
Jet lag	Reviews summarized by the National Center for Complementary and Integrative Health suggest melatonin may reduce overall jet-lag symptoms and may improve sleep after travel, but study quality and outcomes vary 1.	Direction of travel, number of time zones, destination schedule, light exposure, and safety-sensitive plans all affect whether and when it is appropriate.
Shift-work sleep disturbance	A 2025 AASM guideline conditionally supports melatonin for selected sleep periods around shift work, with low or very low certainty depending on the situation 5.	It is not a general alertness aid and should not be taken before driving or working. Rotating schedules may not allow full circadian adaptation.
Other sleep or health uses	Melatonin has been studied in selected pediatric, neurologic, perioperative, and other settings, often using particular populations or formulations.	A result in one condition does not validate a retail supplement for another. Claims about cancer, DNA repair, fertility, hormones, or broad disease prevention require their own clinical evidence and should not guide self-treatment for sleep.

Chronic and persistent insomnia

Insomnia means repeated difficulty falling asleep, staying asleep, or obtaining restorative sleep despite an adequate opportunity, with daytime consequences ³. It is not the same as choosing a late schedule, sleeping at the wrong circadian time, or losing sleep because there is too little time in bed.

The AASM's adult pharmacologic guideline suggests not using melatonin for chronic sleep-onset or sleep-maintenance insomnia. The studies informing that recommendation were limited to a small evidence base in older adults, and the certainty was very low ³. That does not prove that nobody ever notices a benefit. It means the evidence does not support melatonin as a dependable treatment for chronic insomnia in adults.

For chronic insomnia, the AASM strongly recommends multicomponent cognitive behavioral therapy for insomnia, or CBT-I ⁴. CBT-I is more than general sleep-hygiene advice. It combines behavioral and cognitive methods that address the patterns maintaining insomnia.

An evaluation should also look for contributors such as sleep apnea, restless legs symptoms, pain, mood symptoms, medication or substance effects, an inconsistent schedule, or another medical sleep disorder ³. If sleep difficulty persists, keeps returning, or affects daytime safety and functioning, seek cause-led care rather than adding more melatonin.

Circadian-rhythm disorders

Delayed sleep-wake phase disorder is not simply a preference for staying up late. A person has a persistent delay relative to required times, struggles to fall asleep and wake at socially necessary hours, and usually sleeps better when allowed to follow the later schedule ².

Strategically timed melatonin can be part of care for some people with delayed sleep-wake phase disorder, but a plan may also involve timed light, light avoidance, and a stable wake schedule. A clinician may use a sleep diary, activity data, history, and occasionally a biological phase marker to distinguish the disorder from insomnia or an irregular routine ².

The label dose and wall-clock bedtime do not reveal internal circadian phase. Do not copy another person's schedule, move the timing repeatedly after one poor night, or increase the amount because the first use did not feel sedating.

Jet lag

Jet lag is temporary misalignment after travel across time zones. Melatonin may help some travelers, but it is one timing signal within a plan that also includes destination sleep times, correctly timed light and darkness, meals, and alertness needs.

A schedule that helps after eastward travel may be wrong for westward travel or a different departure time. Taking melatonin at the wrong biological time can shift the clock in the unwanted direction. Use our jet lag guide to understand the problem, then ask a clinician or pharmacist for an individualized plan if health conditions, medicines, pregnancy, age, or safety-sensitive work complicate the trip.

Shift work

Shift work can create both sleep loss and circadian misalignment. Melatonin may modestly help sleep in selected circumstances, but the AASM rates much of the evidence as low or very low certainty. Its 2025 guideline warns that melatonin may temporarily increase sleepiness, reduce cognitive performance, and increase accident risk ⁵.

It should not be used to make an unsafe commute or shift tolerable. If a work schedule repeatedly causes insomnia or excessive sleepiness, occupational scheduling, planned sleep opportunities, light management, and a sleep-disorder evaluation may matter more than a supplement.

Why there is no universal dose or timing rule

The appropriate product plan can differ according to:

• Whether the target is circadian phase, sleepiness, or both
• The diagnosed condition and the person's current internal timing
• Travel direction, work schedule, and planned light exposure
• Immediate-release, delayed-release, or extended-release formulation
• Age, pregnancy or breastfeeding, liver or kidney health, and other medical conditions
• Prescription medicines, over-the-counter medicines, alcohol, cannabis, and other supplements
• The need to drive, work, provide care, or make safety-sensitive decisions

Immediate-release and extended-release products do not create the same exposure pattern. A study of one formulation cannot automatically support another, and an extended-release tablet should not be split or crushed unless its instructions allow it.

A larger number on the label is not evidence of greater benefit. Do not combine products, repeat a dose during the night, or escalate after a disappointing result without professional guidance. For circadian use, the wrong timing can matter more than choosing a larger amount.

Side effects and next-day impairment

Short-term studies most often report mild effects such as headache, dizziness, nausea, and sleepiness. Long-term safety is not established, particularly at exposures higher than the body normally produces ¹.

Drowsiness can continue into the next day. Do not drive, cycle, operate machinery, climb, or perform safety-sensitive work if you feel sleepy, dizzy, clumsy, visually impaired, or unable to concentrate. The absence of a “drugged” feeling does not guarantee normal reaction time.

Alcohol can increase impairment and can change how melatonin affects sleep. The National Health Service advises avoiding alcohol and other medicines or herbal products that cause sleepiness while taking melatonin ⁶. Do not combine it with a prescription sleep medicine, sedating antihistamine, opioid, benzodiazepine, cannabis, or another sedating product unless the prescriber or pharmacist has checked the combination.

Stop using the product and seek medical advice for a suspected allergic reaction, severe or persistent symptoms, or a marked change in mood, behavior, balance, or alertness. Use emergency services if someone collapses, has a seizure, has trouble breathing, or cannot be awakened ⁷.

Screen medicines and health conditions first

A supplement can change how a medicine is absorbed, metabolized, or cleared, which can raise or lower medicine exposure. The U.S. Food and Drug Administration advises discussing supplements with a health professional and sharing all prescription medicines, over-the-counter products, vitamins, and other supplements ⁸.

Before using melatonin, ask a clinician or pharmacist to review:

• Anticoagulants or other medicines that affect bleeding
• Epilepsy and antiseizure treatment
• Sleep medicines, anxiety medicines, opioids, sedating antihistamines, or other sedatives
• Medicines that affect mood, blood pressure, blood glucose, immune function, or melatonin metabolism
• Planned surgery or anesthesia
• Dementia, frequent falls, severe daytime sleepiness, or a job that requires sustained vigilance
• Every other supplement or multi-ingredient sleep product

This is a screening list, not a claim that every combination is prohibited. The direction and clinical importance of an interaction can differ by medicine and patient. NCCIH specifically advises medical supervision for people with epilepsy and those taking blood thinners ¹.

Pregnancy and breastfeeding

Research on melatonin supplement safety during pregnancy and breastfeeding is limited ¹. Do not assume that a hormone made by the body is automatically safe at supplemental exposures. Discuss the sleep problem and every product with the prenatal or breastfeeding care team before use.

Older adults

Melatonin may remain active longer in older adults and contribute to daytime drowsiness. NCCIH also notes guidance against using melatonin in people with dementia ¹. Medication burden, cognition, balance, nighttime falls, and the cause of the sleep disturbance all need review before use.

Children and adolescents

Melatonin for a child or teenager belongs in clinician-led care. The AASM advises parents to discuss it with a pediatric health professional because many sleep problems are better addressed through schedules, habits, or behavioral treatment, and the appropriate amount and timing depend on the problem ⁹.

Do not use an adult plan, another child's plan, or a gummy label as pediatric guidance. Long-term developmental safety remains uncertain. Store melatonin like a medication, locked or secured out of children's sight and reach. U.S. poison-center surveillance found a large rise in reported pediatric ingestions from 2012 through 2021, driven mainly by unintentional ingestions in young children ¹⁰.

Product quality and label limits

In the United States, melatonin is sold as a dietary supplement. The FDA is not authorized to approve dietary supplements for safety and effectiveness before they reach the market ¹¹. This does not mean supplements are completely unregulated, but it is a different premarket system from prescription and over-the-counter drugs.

Small market-sampling studies summarized by NCCIH found that many tested melatonin supplements and gummies did not contain the amount stated on the label. Some tested products contained additional compounds not clearly disclosed ¹. These samples do not prove that every current product is inaccurate, but they show why a label claim alone is not a quality test.

If a clinician recommends melatonin:

• Choose a single-ingredient product unless there is a clear reason for every ingredient.
• Look for current independent verification of identity and labeled strength in the verifier's own directory.
• Check the serving size, since the front label may not equal the amount per tablet, dropper, or gummy.
• Match immediate- or extended-release formulation to the clinician's reason for using it.
• Avoid products that promise to treat diseases or use “maximum strength” as proof of effectiveness.
• Keep the original container, lot number, expiration date, and purchase record in case of a reaction or recall.

Independent verification can improve confidence in identity and manufacturing quality. The AASM specifically advises parents to look for a USP Verified product when a pediatric health professional recommends melatonin ⁹. Verification does not prove that melatonin will work for a condition, that the chosen timing is correct, or that long-term use is safe.

If too much was taken

There is no single household cutoff that determines a melatonin overdose. Risk depends on the person, product, actual contents, amount, co-ingestants, symptoms, and intent.

If someone took more than intended, a child accessed the product, or the amount is uncertain, do not wait for severe symptoms or guess what to do. Use the Poison Control online tool or contact the appropriate poison service for individualized instructions ⁷. Keep the container available.

Use emergency services immediately if the person collapses, has a seizure, has trouble breathing, or cannot be awakened. An intentional ingestion or any concern for self-harm also needs immediate emergency and crisis support, even if the person currently looks well.

A practical decision path

1. Name the pattern. Is sleep poor at every time, normal on a preferred late schedule, disrupted by travel, or restricted by shift work?
2. Address the cause. Persistent insomnia, snoring or breathing pauses, uncomfortable legs, pain, mood symptoms, medication effects, and severe daytime sleepiness need appropriate evaluation.
3. Screen safety. Review age, pregnancy or breastfeeding, health conditions, all medicines and supplements, alcohol or sedative use, and the next day's driving or work.
4. Define the treatment target. A circadian shift, temporary jet-lag relief, and treatment of chronic insomnia are not interchangeable goals.
5. Use a verified exact product only if the plan supports it. Match formulation, timing, and amount to the indication rather than copying a generic online schedule.
6. Reassess instead of escalating. If the problem persists, the next step is cause-led care, not a stronger product or indefinite nightly use.

Melatonin is most useful when the diagnosis, biological timing, product, and safety context line up. When those pieces are unknown, starting with an evaluation is more likely to help than starting with a dose.